Related Experiment Video
Updated: Jun 15, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C
Ozlen Atug1, Hakan Akin, Yesim Ozen Alahdab
1Department of Gastroenterology, Marmara University School of Medicine, Istanbul, Turkey. ozlenatug@hotmail.com
Abstract:
Interstitial pneumonitis is a rare but potentially fatal side effect occurring from 2 weeks to 16 weeks after the initiation of treatment with pegylated interferon alpha and ribavirin for chronic hepatitis C.Herein, we present a 68-year-old man with chronic hepatitis C virus infection who developed interstitial pneumonitis association with pegylated interferon after 36 weeks initiation of pegylated interferon-alpha and ribavirin therapy. He did not recover after discontinuation of pegylated interferon/ribavirin and improved by steroid therapy.
Related Concept Videos
Hepatitis
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
